Glenn Greenberg Brave Warrior Advisors
Glenn Greenberg is the founder of Brave Warrior Advisors, a concentrated equity firm that evolved from earlier vehicles including Chieftain Capital. He is known for in-depth research, relatively few holdings, and a focus on businesses with strong competitive positions. Greenberg’s portfolio disclosures attract investors who follow classic fundamental concentration.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bausch Health
BHC
|
+$525M |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$253M |
| 3 |
Cimpress
CMPR
|
+$252M |
| 4 |
Oracle
ORCL
|
+$203M |
| 5 |
Halliburton
HAL
|
+$184M |
Top Sells
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 38.53% |
| 2 | Industrials | 16.55% |
| 3 | Financials | 14.99% |
| 4 | Technology | 13.24% |
| 5 | Energy | 8.49% |
Similar funds
Glenn Greenberg's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Glenn Greenberg, which disclosed 11 positions worth $2.16B. Its ten largest holdings account for 97% of the portfolio.
Its largest position is Bausch Health: 6,657,451 shares worth $573M.
By sector, the portfolio is most concentrated in Healthcare at 39% of assets, followed by Industrials and Financials.
- Glenn Greenberg's largest Q2 2013 buy was Bausch Health: 6,657,451 shares worth $573M.
- Glenn Greenberg's ten largest holdings make up 97% of its $2.16B portfolio in Q2 2013.
- Glenn Greenberg disclosed 11 positions in Q2 2013, its first 13F filing on record.
Based on Brave Warrior Advisors's 13F filing for Q2 2013, filed 14 Aug 2013.